Sleep Apnea Reduced in People Who Took Weight-Loss Drug, Eli Lilly Reports April 17, 2024 Get link Facebook Twitter Pinterest Email Other Apps The company reported results of clinical trials involving Zepbound, an obesity drug in the same class as Novo Nordisk’s Wegovy. Gina Kolata | NYTimes Health | Disclosure Comments
Comments
Post a Comment